OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
036670$5950.0057

Samyang KCI Corp

Specialty ChemicalsVerified

Samyang KCI Corp maintains a strong liquidity position with a current ratio of 5.58, indicating a robust ability to meet short-term obligations. The company's liquidity_fpt of 0.51 suggests a conservative balance sheet with cash and equivalents amounting to 4,936.82 million KRW, which is 3.42% of total assets. The debt-to-equity ratio is effectively zero, reflecting a minimal reliance on debt financing and a strong equity base. Profitability metrics show that Samyang KCI Corp generates a return on equity (ROE) of 7.76% and a return on assets (ROA) of 6.76%, both of which are above the industry median for Specialty Chemicals. The company's gross margin is 29.43%, and its operating margin is 9.33%, indicating efficient cost management and strong operational performance relative to its peers. The company's revenue is concentrated in its core chemical manufacturing business, with no disclosed geographic diversification. All revenue is derived from the production and sale of chemical substances, primarily polymers, surfactants, methyl gluceth, and MPC derivatives. There is no indication of revenue diversification across segments or regions in the latest financial data. Samyang KCI Corp's growth trajectory is supported by a free cash flow of 9,542.79 million KRW and a capital expenditure of -1,869.01 million KRW, suggesting reinvestment in operations. The company's outlook for the current fiscal year indicates a stable revenue trend, with no significant changes in the near term. The operating cash flow is negative at -893.58 million KRW, but this is offset by strong free cash flow generation. Risk factors for Samyang KCI Corp are minimal, with low liquidity and dilution risk scores. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is not expected to change significantly in the near term. The dilution potential is low, with no recent issuance or shelf registration activity reported. The company's financial flexibility is further supported by its strong equity position and low debt levels. Recent events and filings for Samyang KCI Corp do not indicate any material changes in the company's operations or financial position. The latest analyst estimate for EPS is 1,061.00 KRW, reflecting a stable earnings outlook. There are no recent transcripts or filings that suggest significant operational or strategic shifts.

30-day price · 036670-490.00 (-8.1%)
Low$5540.00High$6320.00Close$5590.00As of22 May, 00:00 UTC
Profile
CompanySamyang KCI Corp
Ticker036670.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Samyang KCI Corp is a Korea-based company that primarily engages in the manufacture and sale of chemical substances, including polymers, surfactants, methyl gluceth, and 2-methacryloyloxyethyl phosphorylcholine (MPC) derivatives used in cosmetics and personal care products.

Classification. Samyang KCI Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Samyang KCI Corp maintains a strong liquidity position with a current ratio of 5.58, indicating a robust ability to meet short-term obligations. The company's liquidity_fpt of 0.51 suggests a conservative balance sheet with cash and equivalents amounting to 4,936.82 million KRW, which is 3.42% of total assets. The debt-to-equity ratio is effectively zero, reflecting a minimal reliance on debt financing and a strong equity base. Profitability metrics show that Samyang KCI Corp generates a return on equity (ROE) of 7.76% and a return on assets (ROA) of 6.76%, both of which are above the industry median for Specialty Chemicals. The company's gross margin is 29.43%, and its operating margin is 9.33%, indicating efficient cost management and strong operational performance relative to its peers. The company's revenue is concentrated in its core chemical manufacturing business, with no disclosed geographic diversification. All revenue is derived from the production and sale of chemical substances, primarily polymers, surfactants, methyl gluceth, and MPC derivatives. There is no indication of revenue diversification across segments or regions in the latest financial data. Samyang KCI Corp's growth trajectory is supported by a free cash flow of 9,542.79 million KRW and a capital expenditure of -1,869.01 million KRW, suggesting reinvestment in operations. The company's outlook for the current fiscal year indicates a stable revenue trend, with no significant changes in the near term. The operating cash flow is negative at -893.58 million KRW, but this is offset by strong free cash flow generation. Risk factors for Samyang KCI Corp are minimal, with low liquidity and dilution risk scores. The company has no immediate filing-based liquidity or dilution flags, and its capital structure is not expected to change significantly in the near term. The dilution potential is low, with no recent issuance or shelf registration activity reported. The company's financial flexibility is further supported by its strong equity position and low debt levels. Recent events and filings for Samyang KCI Corp do not indicate any material changes in the company's operations or financial position. The latest analyst estimate for EPS is 1,061.00 KRW, reflecting a stable earnings outlook. There are no recent transcripts or filings that suggest significant operational or strategic shifts.
Key takeaways
  • Samyang KCI Corp has a strong liquidity position with a current ratio of 5.58 and no significant debt.
  • The company's profitability metrics, including ROE of 7.76% and ROA of 6.76%, are above industry medians.
  • Revenue is concentrated in the chemical manufacturing business with no geographic diversification.
  • Free cash flow of 9,542.79 million KRW supports operational reinvestment and financial flexibility.
  • Low liquidity and dilution risk scores indicate a stable capital structure with minimal near-term financial pressure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$116.84B
Gross profit$34.37B
Operating income$10.89B
Net income$9.74B
R&D
SG&A
D&A
SBC
Operating cash flow-$893.6M
CapEx-$1.87B
Free cash flow$9.54B
Total assets$144.23B
Total liabilities$18.70B
Total equity$125.53B
Cash & equivalents$4.94B
Long-term debt$303.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$116.84B$10.89B$9.74B$9.54B
FY-1$110.18B$15.02B$14.71B$15.36B
FY-2$109.95B$10.27B$11.00B$7.49B
FY-3$109.61B$21.88B$17.82B$11.65B
FY-4$81.50B$12.44B$10.16B$4.96B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$144.23B$125.53B$4.94B
FY-1$136.18B$118.49B$26.16B
FY-2$119.31B$106.43B$8.11B
FY-3$123.13B$98.19B$13.28B
FY-4$97.37B$82.57B$6.27B
PeriodOCFCapExFCFSBC
FY0-$893.6M-$1.87B$9.54B
FY-1$24.30B-$1.20B$15.36B
FY-2$19.10B-$5.06B$7.49B
FY-3$13.00B-$7.82B$11.65B
FY-4$7.69B-$6.10B$4.96B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$27.81B$2.11B$2.06B$2.58B
FQ-1$28.67B$1.12B$1.39B$1.88B
FQ-2$32.06B$3.58B$2.88B$3.56B
FQ-3$28.30B$4.09B$3.41B$4.21B
FQ-4$25.28B$2.57B$3.21B$3.72B
FQ-5$25.58B$3.12B$2.50B$3.44B
FQ-6
FQ-7$28.08B$3.32B$3.17B$4.20B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$144.23B$125.53B$4.94B
FQ-1$142.47B$123.51B$6.59B
FQ-2$144.50B$122.11B$4.16B
FQ-3$146.65B$119.28B$8.98B
FQ-4$136.18B$118.49B$26.16B
FQ-5$130.20B$115.26B$19.60B
FQ-6
FQ-7$126.78B$106.89B$13.84B
PeriodOCFCapExFCFSBC
FQ0-$893.6M-$1.87B$2.58B
FQ-1$181.9M-$1.32B$1.88B
FQ-2-$462.3M-$708.2M$3.56B
FQ-3$3.07B-$295.3M$4.21B
FQ-4$24.30B-$1.20B$3.72B
FQ-5$19.01B-$587.9M$3.44B
FQ-6
FQ-7$7.94B-$112.8M$4.20B
Valuation
Market price$5950.00
Market cap$64.02B
Enterprise value$59.39B
P/E6.6
Reported non-GAAP P/E
EV/Revenue0.5
EV/Op income5.5
EV/OCF
P/B0.5
P/Tangible book0.5
Tangible book$125.53B
Net cash$4.63B
Current ratio5.6
Debt/Equity0.0
ROA6.8%
ROE7.8%
Cash conversion-9.0%
CapEx/Revenue-1.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric036670Activity
Op margin9.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin8.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin29.4%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity0.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS1,061.00 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:40 UTC#0a4bff56
Market quoteclose KRW 5950.00 · shares 0.01B diluted
no public URL
2026-05-12 01:40 UTC#ffc3708d
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 01:42 UTCJob: 3f2b4666